Position in VREX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$242,539
+$87,644 QoQ
Shares Held
23,254
+59.3% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#86
of 185 holders
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in VREX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026PRELUDE CAPITAL MANAGEMENT, LLC holds $16,970,515 across 13 Medical Devices names. VREX ranks #8 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PEN |
Penumbra Inc
|
36,381 | $11,487,300 | |
| 2 | 115,133 | $2,864,509 | |||
| 3 | BIO |
Bio-Rad Laboratories, Inc.
|
2,015 | $591,624 | |
| 4 | TNDM |
Tandem Diabetes Care Inc
|
19,002 | $286,740 | |
| 5 | DXCM |
Dexcom Inc
|
3,857 | $259,768 | |
| 6 | RXST |
RxSight, Inc.
|
51,600 | $248,712 | |
| 7 | BVS |
Bioventus Inc.
|
25,780 | $243,363 | |
| 8 | VREX |
Varex Imaging Corp
This page
|
23,254 | $242,539 |
All Filings in VREX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $242,539 | 23,254 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $154,895 | 14,599 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $149,819 | 12,860 | Shares | Other | 2026-02-17 | |
| 2020-09-30 | $13,737 | 1,080 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $8,196 | 541 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $12,286 | 541 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||